Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 129

    1.

    Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).

    Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL; ONTARGET Investigators.

    Am J Cardiol. 2009 Dec 1;104(11):1484-9. Epub 2009 Oct 14.PMID: 19932779 [PubMed - in process]Related articles

    2.

    Polypill: the evidence and the promise.

    Lonn E, Yusuf S.

    Curr Opin Lipidol. 2009 Dec;20(6):453-9.PMID: 19884824 [PubMed - in process]Related articles

    3.

    2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

    Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E.

    Can J Cardiol. 2009 Oct;25(10):567-79. Review.PMID: 19812802 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth.

    Morrison KM, Dyal L, Conner W, Helden E, Newkirk L, Yusuf S, Lonn E.

    Atherosclerosis. 2009 Jul 23. [Epub ahead of print]PMID: 19699477 [PubMed - as supplied by publisher]Related articles

    5.

    Effect of angiotensin-converting enzyme inhibition on C-reactive protein levels: the ramipril C-reactive pRotein randomized evaluation (4R) trial results.

    Verma S, Lonn EM, Nanji A, Browne K, Ward R, Robertson A, Conradson H, Hildebrand K, Brant R, Anderson TJ.

    Can J Cardiol. 2009 Jul;25(7):e236-40.PMID: 19584979 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study.

    Odueyungbo A, Smieja M, Thabane L, Smaill F, Gough K, Gill J, Anderson T, Elston D, Smith S, Beyene J, Lonn E.

    AIDS Res Ther. 2009 Jun 11;6:11.PMID: 19519884 [PubMed - in process]Related articlesFree article

    7.

    Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

    Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) and STARR Investigators.

    J Am Coll Cardiol. 2009 Jun 2;53(22):2028-35.PMID: 19477351 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors.

    Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ.

    Am J Cardiol. 2009 Jun 1;103(11):1610-5. Epub 2009 Apr 8.PMID: 19463524 [PubMed - indexed for MEDLINE]Related articles

    9.

    The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.

    Yan RT, Yan AT, Anderson TJ, Buithieu J, Charbonneau F, Title L, Verma S, Lonn EM.

    Atherosclerosis. 2009 Nov;207(1):232-8. Epub 2009 Apr 16.PMID: 19439301 [PubMed - in process]Related articles

    10.

    The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.

    Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL.

    Clin Res Cardiol. 2009 Jul;98(7):421-33. Epub 2009 Apr 4.PMID: 19347385 [PubMed - indexed for MEDLINE]Related articles

    11.

    Lipid lowering for primary prevention.

    Yusuf S, Lonn E, Bosch J.

    Lancet. 2009 Apr 4;373(9670):1152-5. Review. No abstract available. Erratum in: Lancet. 2009 Jul 4-2009 Jul 10;374(9683):28. PMID: 19345816 [PubMed - indexed for MEDLINE]Related articles

    12.

    5 flourouracil-induced apical ballooning syndrome: a case report.

    Gianni M, Dentali F, Lonn E.

    Blood Coagul Fibrinolysis. 2009 Jun;20(4):306-8.PMID: 19300240 [PubMed - indexed for MEDLINE]Related articles

    13.

    The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

    Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E; HOPE Investigators.

    J Cardiovasc Electrophysiol. 2009 Jul;20(7):781-7. Epub 2009 Feb 27.PMID: 19298567 [PubMed - indexed for MEDLINE]Related articles

    14.

    Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.

    Dentali F, Donadini M, Gianni M, Bertolini A, Lonn E, Venco A, Cattozzo G, Ageno W.

    Intern Emerg Med. 2009 Apr;4(2):123-8. Epub 2009 Feb 27.PMID: 19247590 [PubMed - indexed for MEDLINE]Related articles

    15.

    Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.

    Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E; Heart Outcomes Prevention Evaluation 2 Investigators.

    Stroke. 2009 Apr;40(4):1365-72. Epub 2009 Feb 19.PMID: 19228852 [PubMed - indexed for MEDLINE]Related articles

    16.

    Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome.

    Title LM, Lonn E, Charbonneau F, Fung M, Mather KJ, Verma S, Anderson TJ.

    Vasc Med. 2008 Nov;13(4):263-70.PMID: 18940902 [PubMed - indexed for MEDLINE]Related articles

    17.

    Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).

    Held C, Sumner G, Sheridan P, McQueen M, Smith S, Dagenais G, Yusuf S, Lonn E.

    Vasc Med. 2008 Nov;13(4):245-53.PMID: 18940900 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hemodynamic performance of stentless versus stented valves: a systematic review and meta-analysis.

    Payne DM, Koka HP, Karanicolas PJ, Chu MW, Nagpal AD, Briel M, Schünemann HJ, Lonn EM.

    J Card Surg. 2008 Sep-Oct;23(5):556-64. Review.PMID: 18928495 [PubMed - indexed for MEDLINE]Related articles

    19.

    Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

    Am J Cardiol. 2008 Sep 15;102(6):733-7. Epub 2008 Jul 9.PMID: 18773998 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical Evidence: Emerging approaches in preventing cardiovascular disease.

    Lonn EM, Yusuf S.

    West J Med. 1999 Oct;171(4):247-252. No abstract available. PMID: 18751188 [PubMed - as supplied by publisher]Related articlesFree article

    21.

    Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

    Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC.

    Can J Cardiol. 2008 May;24 Suppl A:3A-8A. Review.PMID: 18437251 [PubMed - indexed for MEDLINE]Related articles

    22.

    Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?

    Lonn E.

    JAMA. 2008 May 7;299(17):2086-7. No abstract available. PMID: 18460669 [PubMed - indexed for MEDLINE]Related articles

    23.

    BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.

    Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H.

    Eur J Heart Fail. 2008 Mar;10(3):252-9.PMID: 18331967 [PubMed - indexed for MEDLINE]Related articles

    25.

    Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

    DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S.

    Diabetes Care. 2008 May;31(5):1007-14. Epub 2008 Feb 11.PMID: 18268075 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    The effect of large unilamellar vesicles on vascular function in patients with coronary atherosclerosis.

    Anderson T, Charbonneau F, Chan S, Lonn E.

    Atherosclerosis. 2008 Oct;200(2):424-31. Epub 2008 Feb 8.PMID: 18262192 [PubMed - indexed for MEDLINE]Related articles

    27.

    Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.

    Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima-Media Thickness Task Force.

    J Am Soc Echocardiogr. 2008 Feb;21(2):93-111; quiz 189-90. Review. No abstract available. Erratum in: J Am Soc Echocardiogr. 2008 Apr;21(4):376. PMID: 18261694 [PubMed - indexed for MEDLINE]Related articles

    28.

    Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis.

    Merchant AT, Kelemen LE, de Koning L, Lonn E, Vuksan V, Jacobs R, Davis B, Teo KK, Yusuf S, Anand SS; SHARE and SHARE-AP investigators.

    Am J Clin Nutr. 2008 Jan;87(1):168-74.PMID: 18175752 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.

    Mann JF, Sheridan P, McQueen MJ, Held C, Arnold JM, Fodor G, Yusuf S, Lonn EM; HOPE-2 investigators.

    Nephrol Dial Transplant. 2008 Feb;23(2):645-53. Epub 2007 Nov 14.PMID: 18003666 [PubMed - indexed for MEDLINE]Related articles

    30.

    Randomized clinical trial of homocysteine level lowering therapy and fractures.

    Sawka AM, Ray JG, Yi Q, Josse RG, Lonn E.

    Arch Intern Med. 2007 Oct 22;167(19):2136-9. No abstract available. PMID: 17954810 [PubMed - indexed for MEDLINE]Related articles

    32.

    [Wrong focus in the debate on burnout]

    Keresztesi G, Lönn E.

    Lakartidningen. 2007 Aug 29-Sep 4;104(35):2446. Swedish. No abstract available. PMID: 17902418 [PubMed - indexed for MEDLINE]Related articles

    33.

    Venous thromboembolism in association with features of the metabolic syndrome.

    Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Kearon C; HOPE-2 investigators, Yusuf S, Arnold MJ, McQueen MJ, Pogue J, Probstfield J, Fodor G, Held C, Micks M, Genest J Jr.

    QJM. 2007 Nov;100(11):679-84. Epub 2007 Sep 10.PMID: 17846056 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.

    Salehian O, Healey J, Stambler B, Alnemer K, Almerri K, Grover J, Bata I, Mann J, Matthew J, Pogue J, Yusuf S, Dagenais G, Lonn E; HOPE Investigators.

    Am Heart J. 2007 Sep;154(3):448-53.PMID: 17719288 [PubMed - indexed for MEDLINE]Related articles

    35.

    Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population.

    Grewal J, Anand S, Islam S, Lonn E; SHARE and SHARE-AP Investigators.

    Atherosclerosis. 2008 Mar;197(1):435-42. Epub 2007 Aug 6.PMID: 17675040 [PubMed - indexed for MEDLINE]Related articles

    36.

    Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).

    Charbonneau F, Anderson TJ, Title L, Jobin J, Poirier P, Huyhn T, Chan S, Walling A, Hutchison S, Tran T, Lonn E, Buithieu J, Genest J.

    Atherosclerosis. 2008 Mar;197(1):420-7. Epub 2007 Aug 1.PMID: 17673219 [PubMed - indexed for MEDLINE]Related articles

    37.

    Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

    Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E; Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators.

    Ann Intern Med. 2007 Jun 5;146(11):761-7. Epub 2007 Apr 30.PMID: 17470822 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.

    Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E.

    Eur Heart J. 2007 Jun;28(11):1382-8. Epub 2007 Mar 29.PMID: 17395677 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters.

    Campbell NR, McKay DW, Conradson H, Lonn E, Title LM, Anderson T.

    J Hum Hypertens. 2007 Jul;21(7):588-90. Epub 2007 Mar 22. No abstract available. PMID: 17377600 [PubMed - indexed for MEDLINE]Related articles

    40.

    Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

    Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, Ostergren J, McKelvie RS; Investigators of the CHARM Echocardiographic Substudy-CHARMES.

    J Am Coll Cardiol. 2007 Feb 13;49(6):687-94. Epub 2007 Jan 26.PMID: 17291934 [PubMed - indexed for MEDLINE]Related articles

    41.

    Giant left atrial myxoma and associated mitral valve pathology.

    Whitlock R, Evans R, Lonn E, Teoh K.

    J Cardiothorac Vasc Anesth. 2007 Feb;21(1):103-5. Epub 2006 Feb 21. No abstract available. PMID: 17289492 [PubMed - indexed for MEDLINE]Related articles

    42.

    A traditional society in change encounters HIV/AIDS: knowledge, attitudes, and risk behavior among students in northwestern China.

    Lönn E, Sahlholm K, Maimaiti R, Abdukarim K, Andersson R.

    AIDS Patient Care STDS. 2007 Jan;21(1):48-56.PMID: 17263657 [PubMed - indexed for MEDLINE]Related articles

    43.

    Impact of ramipril on the circadian periodicity of acute myocardial infarction.

    Dagenais GR, Pogue J, Teo KK, Lonn EM, Yusuf S; HOPE Study Investigators.

    Am J Cardiol. 2006 Sep 15;98(6):758-60. Epub 2006 Jul 28.PMID: 16950179 [PubMed - indexed for MEDLINE]Related articles

    44.

    The effect of iron status on vascular health.

    Yunker LM, Parboosingh JS, Conradson HE, Faris P, Bridge PJ, Buithieu J, Title LM, Charbonneau F, Verma S, Lonn EM, Anderson TJ.

    Vasc Med. 2006 May;11(2):85-91.PMID: 16886838 [PubMed - indexed for MEDLINE]Related articles

    45.

    Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions.

    Lonn E, Grewal J.

    Curr Vasc Pharmacol. 2006 Jul;4(3):253-68. Review.PMID: 16842143 [PubMed - indexed for MEDLINE]Related articles

    46.

    Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

    Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S; HOPE Study Investigators.

    Circulation. 2006 Jul 18;114(3):201-8. Epub 2006 Jul 10.PMID: 16831981 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review.

    Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E.

    Eur Heart J. 2006 Jul;27(13):1523-9. Epub 2006 May 23. Review.PMID: 16720686 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Homocysteine lowering with folic acid and B vitamins in vascular disease.

    Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.

    N Engl J Med. 2006 Apr 13;354(15):1567-77. Epub 2006 Mar 12. Erratum in: N Engl J Med. 2006 Aug 17;355(7):746. PMID: 16531613 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

    Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S; HOPE-2 Investigators.

    Can J Cardiol. 2006 Jan;22(1):47-53.PMID: 16450017 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?

    Gupta M, Lonn EM, Verma S.

    Nat Clin Pract Cardiovasc Med. 2005 Mar;2(3):124-5. No abstract available. PMID: 16265450 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...